SPECIALS

Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond

T. Feys, G. Roex, Y. Beguin, T. Kerre, X. Poiré, P. Lewalle, P. Vandenberghe, D. Bron, S. Anguille

Antibody-drug conjugates in the treatment of haematological malignancies

J. Blokken, T. Feys

The role of immunotherapy in the treatment of classic Hodgkin lymphoma

A. Van Besien, G. Verhoef, D. Dierickx

Anti-CD38 monoclonal antibodies in the treatment of multiple myeloma

S. Vlayen, N. Kint, M. Delforge

Bispecific T-cell engagers (BiTEs) in haematological malignancies

T. Feys, J. Blokken